Covington advised Humacyte on the deal. Humacyte, Inc. announced its $150 million revenue-based funding arrangement, as well as a $10 million equity investment option, with Oberland...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Roivant Sciences Ltd. in the deal, while Covington represented the underwriter, Cantor Fitzgerald. Roivant Sciences Ltd. announced its debut SEC-registered offering of 30,000,000...
You must be a Standard 1 Year member to access this content.
White & Case advised AMCI, Covington & Burling advised LanzaTech, Ropes & Gray advised the placement agents on the deal. AMCI Acquisition Corp. II, a publicly...
You must be a Standard 1 Year member to access this content.
